Thrombosis
Commentary
The new NOACs are generally the best bet
Commentary
Commentary: INR instability in the NOAC era
Conference Coverage
VIDEO: NOACs cut intracranial bleeds in real-world atrial fib patients
News
Solid INRs on warfarin don’t predict future stability
Six months of stable INRs while on warfarin therapy doesn’t predict continued INR stability.
Conference Coverage
As preventive, H2RA poses risks for patients on clopidogrel after bleeding ulcer
SAN DIEGO – New research suggests histamine-2 receptor antagonists aren’t a viable alternative to proton pump inhibitors to prevent recurrence of...
News
Tyrosine kinase inhibitors may boost cardiac risk in chronic myeloid leukemia
Tyrosine kinase inhibitors were associated with a significantly increased risk of cardiovascular events among chronic myeloid leukemia patients....
Conference Coverage
TAVR cerebral protection device appears safe, effective
PARIS – No strokes seen with TriGuard device in pooled analysis.
Conference Coverage
CT renders transesophageal echo largely avoidable in TAVR
Key clinical point: It’s essential to look for left atrial appendage thrombus in all TAVR candidates, and second-generation CT scanning offers...
Conference Coverage
Prasugrel beats clopidogrel for complex PCI in ACS
PARIS – Sharply lower 1-year mortality and MACE rates were seen with prasugrel in the PROMETHEUS study.
Conference Coverage
Anticoagulation therapy after VT ablation yields fewer thrombotic events
Key clinical point: Anticoagulant therapy may be a good idea after ventricular tachycardia ablation in patients with risk factors for stroke, even...